Irregular heartbeat conditions affect millions of people worldwide, causing hearts to beat too fast, too slow, or with an uneven rhythm. These cardiac rhythm disturbances, medically known as ...

New research explains how low levels of the electrolyte sodium in the blood can disrupt the timing of the heartbeat in patients taking widely used rhythm-control medications such as flecainide, which ...

CHICAGO, IL (updated) — Either strategy may be more appropriate in individual patients, but overall, atrial fibrillation developing after heart surgery responds similarly to either rate-control or ...

Omaha, NE - The results of a recent study have shown a trend toward a lower rate of early atrial fibrillation (AF) recurrence at 24 hours after direct-current (DC) cardioversion in patients receiving ...

An analysis of patient-operated ECGs from the EAST—AFNET 4 trial revealed: A low AF burden below 6% in the first year of early rhythm control therapy was associated with low cardiovascular event rates ...

CHICAGO, IL—A quality-improvement program from the Heart Rhythm Society was associated with improvements in care for patients early after they received a diagnosis of atrial fibrillation (AF), ...

New research explains how low levels of the electrolyte sodium in the blood can disrupt the timing of the heartbeat in patients taking widely used rhythm-control medications such as flecainide, which ...

Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic ...

Steven Poelzing (left) and Gregory Hoeker, researchers at the Fralin Biomedical Research Institute at VTC, collaborated on a new study published in the journal Heart Rhythm revealing why low blood ...